Post compression parameters for core bilayer tablets
A THEORETICAL PROSPECTIVE OF BILAYER MATRIX TABLETS
16
Design and evaluation of bilayer floating tablets of metronidazole and ranitidine
12
PREFORMULATION, PRCOMPRESSION AND POST COMPRESSION EVALUATION OF BILAYER TABLET OF ASPIRIN AS IMMEDIATE RELEASE AND NICOTINIC ACID AS SUSTAINED RELEASE
16
Formulation and Evaluation of Bilayer Matrix Tablets of Nebivolol Hydrochloride and Valsartan
12
FORMULATION AND EVALUATION OF BILAYER TABLETS OF BACLOFEN USING SYNTHETIC POLYMERS
7
Formulation and Evaluation of Bilayer Tablets of Metformin Hydrochloride SR and Vildagliptin IR
83
Formulation and Evaluation of Sustained Release Bilayer Tablets of Glimepiride and Metformin HCl.
69
Formulation and Evaluation of Immediate Release Bilayer Tablets of Anti Retroviral Drugs
143
FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE BILAYER TABLETS OF TELMISERTAN AND HYDROCHLOROTHIAZIDE
6
Formulation and evaluation of immediate release bilayer tablets of telmisartan and amlodipine besylate
10
Formulation and Evaluation of Lurasidone Bilayer Tablets
131
FORMULATION AND DEVELOPMENT OF LORNOXICAM BILAYER TABLETS
7
Formulation and Evaluation of Omeprazole and Domperidone Bilayer Tablets.
144
FORMULATION AND EVALUATION OF BILAYER TABLETS OF ACECLOFENAC AND ALLOPURINOL
14
Design and Invitro Evaluation of Silymarin Bilayer Tablets
6
Formulation and evaluation of amlodipine and metoprolol bilayer tablets
18
Formulation and Evaluation of Bilayer Tablets of Metformin Hydrochloride
6
Formulation and Evaluation of Bilayer Floating Tablets for Diabetes Mellitus.
181
Formulation and In-Vitro Evaluation of Bilayer Tablets of Sumatriptan Succinate.
153
Development and Evaluation of Sustained Release Bilayer Tablets of Carvedilol.
113